Thionated donor-acceptor naphthalimides as efficient heavy-atom-free triplet photosensitizers for type I/II ROS generation in hypoxia-immune photodynamic therapy
Acta Biomaterialia · 2026-06 · 217 · 651-664
DOI: 10.1016/j.actbio.2026.04.047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-06. Verfasst von Qian Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Fiber Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China. Hauptthemen laut MEDLINE: Photochemotherapy, Photosensitizing Agents, Reactive Oxygen Species, Naphthalimides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Vetenskapsrådet.
Abstract (Originalsprache)
Photodynamic therapy (PDT) is a promising non-invasive cancer treatment but faces challenges from the hypoxic tumor environment and inefficient reactive oxygen species (ROS) generation. To address this, we designed a series of donor-acceptor naphthalimide derivatives via synergistic integration of electron-donating groups and stepwise thionation of the NI core, achieving ROS generation even under hypoxia. The donor-acceptor structure and stepwise thionation synergistically extend absorption to the 500-700 nm red light region and reduce the singlet-triplet energy gap (ΔEST), thereby enhancing triplet state population and boosting ROS generation efficiency. Among them, NI-OCH3-2S exhibits the lowest ΔEST (0.114 eV) and the highest T1 state yield (28 %). Under red light irradiation, NI-OCH₃-2S demonstrates efficient 1O2 (Φ = 44 %) and O2-· generation under hypoxia. After encapsulation by PLGA-PEG and targeted PLGA-PEG-FA, the resulting NI NPs produced ROS induce oxidative stress and lead to mitochondrial dysfunction, activating the caspase-3-mediated apoptosis pathway. In vivo, NI NPs effectively targeted tumors and their generated ROS remodeled the tumor immune microenvironment by repolarizing immunosuppressive M2-TAMs toward the pro-inflammatory M1 phenotype, increasing the M1/M2 ratio by 4.8-fold. ROS-induced tumor cell damage also recruited dendritic cells to tumor sites. These DCs then migrated to secondary lymphoid organs, where they activated splenic helper T cells (CD3+CD4+, 37.8 %) and cytotoxic T lymphocytes (CD3+CD8+, 20.6 %), establishing a systemic anti-tumor immune response. In 4T1-bearing mice, NI NPs achieved 71 % tumor suppression with negligible toxicity, enabling hypoxia-immune synergistic PDT. This study presents a rational design strategy for efficient heavy-atom-free type I/II PSs, addressing ROS inefficiency, hypoxia, and immunosuppression to advance hypoxia-immune synergistic PDT. STATEMENT OF SIGNIFICANCE: Photodynamic therapy (PDT) is hindered by hypoxic tumor microenvironments and insufficient reactive oxygen species generation. Here, we develop a heavy-atom-free donor-acceptor naphthalimide photosensitizer NI-OCH3-2S via synergistic electron-donating group introduction and stepwise thionation. This design extends red-light absorption, narrows the singlet-triplet energy gap, and enables efficient production of both oxygen-dependent 1O2 and oxygen-independent O2-· even under hypoxia. Encapsulated into targeted PLGA-PEG-FA nanoparticles, the photosensitizer NI NPs induces mitochondrial apoptosis and remodels the immunosuppressive tumor microenvironment by repolarizing M2-like macrophages to the M1 phenotype and activating systemic T cell immunity. In 4T1 tumor-bearing mice, NI NPs generated ROS achieve 71 % tumor growth inhibition with low toxicity, providing a generalizable strategy for hypoxia-resistant, immune-modulatory PDT with clinical translation potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Advanced Fiber Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China.
- State Key Laboratory of Advanced Fiber Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China. Electronic address: wenmei@dhu.edu.cn.
- Laboratory of Organic Electronics and Wallenberg Wood Science Center, Linköping University, Norrköping 60174, Sweden.
- Institute of Advanced Materials, Faculty of Chemistry, Wrocław University of Science and Technology, PL-50370 Wrocław, Poland.
- Institute of Advanced Materials, Faculty of Chemistry, Wrocław University of Science and Technology, PL-50370 Wrocław, Poland; Department of Physics and Astronomy, Uppsala University, Box 516, SE-751 20 Uppsala, Sweden.
- State Key Laboratory of Advanced Fiber Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China. Electronic address: zgchen@dhu.edu.cn.
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Vetenskapsrådet
- European Research Council
- Linköpings Universitet
- European Commission
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Chen, Q., Wen, M., Yu, N., Niu, S., Baryshnikov, G., Ali, A., Ågren, H., Chen, Z., Chen, F., & Zhu, M. (2026). Thionated donor-acceptor naphthalimides as efficient heavy-atom-free triplet photosensitizers for type I/II ROS generation in hypoxia-immune photodynamic therapy. Acta Biomaterialia, 217, 651-664. https://doi.org/10.1016/j.actbio.2026.04.047
Vancouver
Chen Q, Wen M, Yu N, Niu S, Baryshnikov G, Ali A, et al. Thionated donor-acceptor naphthalimides as efficient heavy-atom-free triplet photosensitizers for type I/II ROS generation in hypoxia-immune photodynamic therapy. Acta Biomaterialia. 2026;217:651-664. doi:10.1016/j.actbio.2026.04.047
BibTeX
@article{Chen2026,
author = {Chen, Qian and Wen, Mei and Yu, Nuo and Niu, Shining and Baryshnikov, Glib and Ali, Amjad and Ågren, Hans and Chen, Zhigang and Chen, Fengkun and Zhu, Meifang},
title = {Thionated donor-acceptor naphthalimides as efficient heavy-atom-free triplet photosensitizers for type I/II ROS generation in hypoxia-immune photodynamic therapy},
journal = {Acta Biomaterialia},
year = {2026},
volume = {217},
pages = {651--664},
doi = {10.1016/j.actbio.2026.04.047}
}
EUVIMED